Please find enclosed

September 23, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block, Bandra Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 SCRIP CODE: 543748 SYMBOL: AARTIPHARM Dear Sir/Madam, Sub: Updates on Change in Directorate Ref: Regulation 30 of SEBI (LODR) Regulations, 2015 Pursuant to Regulation 30 read with Part A of Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI (LODR) Regulations, 2015") and based on the voting results of the 7th Annual General Meeting (AGM) submitted vide Scrutiniser’s report dated September 23, 2026, we hereby inform you that the Members of the Company, at the 7th AGM held on September 22, 2026, have approved the following changes in the Directorate:  Shri Rajendra Gogri (DIN: 00061003), Non-Executive Non-Independent Director of the Company, who was liable to retire by rotation at the 7th AGM and did not offer himself for re-appointment, accordingly ceased to be a Director on the Board of the Company with effect from the conclusion of the 7th AGM held on September 22, 2026;  Smt. Hetal Gogri Gala (DIN: 00005499) be re-designated from Managing Director to Whole-time Director of the Company with effect from October 1, 2026; and  Shri. Rashesh C. Gogri (DIN:00066291) be appointed as the Managing Director of the Company pursuant to change in his designation from Non-Executive Director to Managing Director, with effect from October 1, 2026. The disclosures required under Regulation 30 of the SEBI Listing Regulations read with Part A of Schedule III of the SEBI Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed herewith as Annexure- A. The above information is also available on the website of the Company: www.aartipharmalabs.com Please take the same on your records. Thanking you, Yours faithfully, For AARTI PHARMALABS LIMITED JEEVAN MONDKAR COMPANY SECRETARY AND LEGAL HEAD ICSI M. NO. A22565 Encl: a/a Annexure – A SR. Particulars Disclosure Shri Rajendra V. Gogri Shri Rashesh Gogri Smt. Hetal Gogri Gala (DIN: 00061003) (DIN: 00066291) (DIN: 00005499) 1 Reason for change viz. On the basis of Change in role Change in role appointment, re- recommendations of the appointment, Board of Directors, resignation, removal, shareholders have death or otherwise approved non re- appointment of Shri Rajendra V. Gogri, as a Non Executive Director of the Company who was liable to retire by rotation but did not offer himself for re- appointment. 2 Date of appointment/re- Date of cessation: Date of Change in role: Date of Change in role: appointment/cessation September 22, 2026 October 01, 2026 October 01, 2026 (as applicable) & term of appointment/re- On conclusion of the 7th appointment; AGM held on September 22, 2026 and based on the voting results of AGM submitted vide Scrutiniser’s report dated September 23, 2026 3 Brief profile Not Applicable Not Applicable (since it Not Applicable (since it is (In case of Appointment is change in role and not change in role and not a of Director) a new appointment) new appointment) 4 Disclosure of Not Applicable Not Applicable (since it Not Applicable (since it is relationships between is change in role and not change in role and not a directors (in case of a new appointment) new appointment) appointment of a director) However, Shri Rashesh However, Shri Rashesh C. Gogri and Smt. Hetal C. Gogri and Smt. Hetal Gogri Gala are related to Gogri Gala are related to each other each other